• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在考虑年龄、肿瘤直径、侵袭性生长和转移等因素时,组织学不影响分化型甲状腺癌的预后。

Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.

作者信息

Verburg Frederik A, Mäder Uwe, Luster Markus, Reiners Christoph

机构信息

Department of Nuclear Medicine, Würzburg University, Würzburg, Germany.

出版信息

Eur J Endocrinol. 2009 Apr;160(4):619-24. doi: 10.1530/EJE-08-0805. Epub 2009 Jan 21.

DOI:10.1530/EJE-08-0805
PMID:19158232
Abstract

OBJECTIVE

Papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) show considerable differences in disease stage at initial presentation. The aim of this study was to investigate whether there are differences in tumour-specific survival if initial staging is accounted for.

DESIGN

Retrospective chart review study.

PATIENTS

The study sample comprised 875 PTC and 350 FTC patients (856 females, 369 males, mean age 47.8 years) treated in our hospital from 1978 to 2002. All patients received total thyroidectomy with subsequent I-131 ablation except for those patients with an isolated papillary microcarcinoma.

METHODS

Kaplan-Meier analyses and Cox-regression analyses were performed to assess the influence of histology on thyroid cancer-specific survival.

RESULTS

FTC patients were on average older, more likely to be male, presented with a larger tumour and more frequently had multifocal carcinoma and distant metastases than PTC patients, whereas they presented less frequently with extrathyroidal invasion or lymph node metastases. Twenty-year tumour-specific survival in PTC was 90.6% and in FTC 73.7% (P<0.001). In multivariate analysis the presence of distant metastases (P<0.001), age (P<0.001), tumour size (P=0.001) and the presence of extrathyroidal invasion (P=0.007), but not histology (P=0.26), were independent determinant variables for tumour-specific survival.

CONCLUSION

There is no difference in tumour-specific survival between PTC and FTC when accounting for the presence of metastases, age, tumour size and the presence of extrathyroidal invasion.

摘要

目的

甲状腺乳头状癌(PTC)和甲状腺滤泡状癌(FTC)在初次就诊时疾病分期存在显著差异。本研究旨在探讨如果考虑初始分期,肿瘤特异性生存率是否存在差异。

设计

回顾性病历审查研究。

患者

研究样本包括1978年至2002年在我院接受治疗的875例PTC患者和350例FTC患者(856例女性,369例男性,平均年龄47.8岁)。除孤立性乳头状微小癌患者外,所有患者均接受了甲状腺全切术及后续的I - 131消融治疗。

方法

进行Kaplan - Meier分析和Cox回归分析,以评估组织学对甲状腺癌特异性生存的影响。

结果

与PTC患者相比,FTC患者平均年龄更大,男性比例更高,肿瘤更大,多灶性癌和远处转移更常见,而甲状腺外侵犯或淋巴结转移较少见。PTC患者的20年肿瘤特异性生存率为90.6%,FTC患者为73.7%(P<0.001)。多变量分析中,远处转移的存在(P<0.001)、年龄(P<0.001)、肿瘤大小(P = 0.001)和甲状腺外侵犯的存在(P = 0.007)是肿瘤特异性生存的独立决定变量,而组织学(P = 0.26)不是。

结论

当考虑转移的存在、年龄、肿瘤大小和甲状腺外侵犯的存在时,PTC和FTC的肿瘤特异性生存率没有差异。

相似文献

1
Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.在考虑年龄、肿瘤直径、侵袭性生长和转移等因素时,组织学不影响分化型甲状腺癌的预后。
Eur J Endocrinol. 2009 Apr;160(4):619-24. doi: 10.1530/EJE-08-0805. Epub 2009 Jan 21.
2
Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.甲状腺乳头状癌的乳头状和滤泡状变体:初始表现及对治疗的反应
Otolaryngol Head Neck Surg. 2005 Jun;132(6):840-4. doi: 10.1016/j.otohns.2005.02.002.
3
Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.基于肿瘤组织学类型和灶性的甲状腺乳头状癌中央区淋巴结转移
Arch Otolaryngol Head Neck Surg. 2010 Jul;136(7):692-6. doi: 10.1001/archoto.2010.112.
4
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.同质管理的pT3分化型甲状腺癌人群中的复发风险。
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
5
Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.乳头状和滤泡状甲状腺癌的预后因素:它们对癌症分期的影响。
Ann Surg Oncol. 2007 Feb;14(2):730-8. doi: 10.1245/s10434-006-9207-5. Epub 2006 Nov 11.
6
Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.碘充足的地方性甲状腺肿地区的滤泡性甲状腺癌:一项前瞻性收集、回顾性分析的临床试验。
Ann Surg. 2009 Jun;249(6):1023-31. doi: 10.1097/SLA.0b013e3181a77b7b.
7
Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.乳头状和滤泡状甲状腺癌的病理肿瘤-淋巴结-转移(pTNM)分期:700例患者的回顾性分析
J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62. doi: 10.1210/jcem.82.11.4373.
8
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.初始手术和药物治疗对乳头状和滤泡状甲状腺癌的长期影响。
Am J Med. 1994 Nov;97(5):418-28. doi: 10.1016/0002-9343(94)90321-2.
9
Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.乳头状和滤泡状甲状腺癌的无病生存期。UICC第5版和第7版T分期分类的比较以及原发肿瘤大小的预后价值。
Nuklearmedizin. 2013;52(3):71-80. doi: 10.3413/Nukmed-0530-12-09. Epub 2013 Mar 13.
10
Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.滤泡型甲状腺乳头状癌是一种独特的临床实体:基于人群的 10740 例病例研究。
Thyroid. 2013 Oct;23(10):1263-8. doi: 10.1089/thy.2012.0453. Epub 2013 Sep 11.

引用本文的文献

1
Decoding the basis of histological variation in human cancer.解析人类癌症组织学变异的基础。
Nat Rev Cancer. 2024 Feb;24(2):141-158. doi: 10.1038/s41568-023-00648-5. Epub 2023 Dec 22.
2
Follicular Thyroid Carcinoma in a Developing Country: A 10-Year Retrospective Study.发展中国家的滤泡性甲状腺癌:一项10年回顾性研究
Cureus. 2021 Jul 23;13(7):e16594. doi: 10.7759/cureus.16594. eCollection 2021 Jul.
3
Advanced thyroid carcinomas: neural network analysis of ultrasonographic characteristics.晚期甲状腺癌:超声特征的神经网络分析
Thyroid Res. 2021 Jun 29;14(1):16. doi: 10.1186/s13044-021-00107-z.
4
Sonographic Features Differentiating Follicular Thyroid Cancer from Follicular Adenoma-A Meta-Analysis.超声特征鉴别滤泡状甲状腺癌与滤泡性腺瘤的Meta分析
Cancers (Basel). 2021 Feb 24;13(5):938. doi: 10.3390/cancers13050938.
5
High incidence of mutations in follicular thyroid cancer: potential therapeutic target in patients with advanced disease stage.滤泡状甲状腺癌中高发生率的突变:晚期疾病患者的潜在治疗靶点。
Ther Adv Med Oncol. 2020 Mar 4;12:1758835920907534. doi: 10.1177/1758835920907534. eCollection 2020.
6
Prognosis of FTC compared to PTC and FVPTC: findings based on SEER database using propensity score matching analysis.与乳头状甲状腺癌(PTC)和滤泡状乳头状甲状腺癌(FVPTC)相比,滤泡状甲状腺癌(FTC)的预后:基于监测、流行病学和最终结果(SEER)数据库使用倾向评分匹配分析的结果
Am J Cancer Res. 2018 Aug 1;8(8):1440-1448. eCollection 2018.
7
High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma.高甲状腺球蛋白抗体水平会增加分化型甲状腺癌的风险。
Dis Markers. 2015;2015:648670. doi: 10.1155/2015/648670. Epub 2015 Oct 27.
8
Endogenous TSH levels at the time of I ablation do not influence ablation success, recurrence-free survival or differentiated thyroid cancer-related mortality.I消融时的内源性促甲状腺激素水平不影响消融成功率、无复发生存率或分化型甲状腺癌相关死亡率。
Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):224-231. doi: 10.1007/s00259-015-3223-2. Epub 2015 Oct 23.
9
Determinants of successful ablation and complete remission after total thyroidectomy and ¹³¹I therapy of paediatric differentiated thyroid cancer.小儿分化型甲状腺癌全甲状腺切除及¹³¹I治疗后成功消融和完全缓解的决定因素。
Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1390-8. doi: 10.1007/s00259-015-3076-8. Epub 2015 Jun 13.
10
Cerebral metastases from thyroid carcinoma: complete remission following radioiodine treatment.甲状腺癌脑转移:放射性碘治疗后完全缓解
Dtsch Arztebl Int. 2013 Dec 13;110(50):861-6. doi: 10.3238/arztebl.2013.0861.